Advanced Intellectual Property Strategies for Defending Your Life Sciences IPO

One of the greatest fears of a life sciences company is the possibility of being sued for intellectual property violation shortly before their IPO. Such a lawsuit can destabilize market confidence in the company, raise questions on whether or not the product will ever come to market, or it can halt the IPO. Attorneys Cyrus Morton and Jake Holdreith explain what life science companies can do to mitigate and avoid these aforementioned risks.

Embed Video

Copy

Topics:  Intellectual Property Litigation, IPO, Life Sciences, Risk Assessment, Risk Management

Published In: Intellectual Property Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robins, Kaplan, Miller & Ciresi L.L.P. | Attorney Advertising

CONNECT

Founded in 1938, Robins, Kaplan, Miller & Ciresi L.L.P. is a litigation firm that serves clients –... View Profile »


Follow Robins, Kaplan, Miller & Ciresi L.L.P.:

Reporters on Deadline